Prospective epidemiological studies have consistently demonstrated that cannabis use is
associated with an increased subsequent risk of both psychotic symptoms and …

Abstract Purpose of Review The lack of clarity about the effect of cannabis use on cognition
may be attributable to the considerable heterogeneity among studies in terms of cannabis …

Background and objectives Cognitive impairment is a core symptom domain of
schizophrenia, neurological disorders and substance abuse. It is characterised by deficits in …

Despite cannabidiol (CBD) having numerous cardiovascular effects in vitro, its
haemodynamic effects in vivo are unclear. Nonetheless, the clinical use of CBD (Epidiolex) …

Introduction 5F‐ADBINACA, AB‐FUBINACA, and STS‐135 are 3 novel third‐generation
fluorinate synthetic cannabinoids that are illegally marketed as incense, herbal preparations …

Cannabis use represents a major public health issue throughout the globe. Yet, we still lack
the most fundamental knowledge on long-term effects of cannabis on neural, cognitive, and …

Recent interest for the use of cannabis-derived products as therapeutic agents in the
treatment of epilepsies has necessitated a reevaluation of their effects on brain and …

Recent research suggests that perceptual abnormalities are a group of diverse experiences,
which have been associated with trauma, cannabis use, and anxiety. Of the attenuated …

Psychotic disorders such as schizophrenia are widespread and severely disabling;
however, current pharmacological treatments are unsatisfactory due to major side effects …

Accumulating evidence suggests that dysfunction within the endocannabinoid (eCB) system
may play a role in psychosis. However, little is understood about how this may be related to …